1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Petros, A.M. Medek, A. Nettesheim, D.G. Kim, D.H. Yoon, H.S. Swift, K. Matayoshi, E.D. Oltersdorf, T. Fesik, S.W. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 98 3012 3017 10.1073/pnas.041619798 11248023 Solution structure of the antiapoptotic protein bcl-2. 2001 US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 83 5214 5218 Analysis of the structure, transcripts, and products of bcl-2, the gene involved in human follicular lymphoma 1986 10.2210/pdb1g5m/pdb pdb_00001g5m 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 19227.389 PROTEIN (APOPTOSIS REGULATOR BCL-2 WITH PUTATIVE FLEXIBLE LOOP REPLACED WITH A PORTION OF APOPTOSIS REGULATOR BCL-X PROTEIN) 1 man polymer no no MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDDVEENRTEAPEGTESEVVHLALRQAGDDFSRRYRGDFAEMSSQLHL TPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVEL YGPSMR MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDDVEENRTEAPEGTESEVVHLALRQAGDDFSRRYRGDFAEMSSQLHL TPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVEL YGPSMR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample 9606 Homo sapiens 562 Escherichia coli database_2 pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations Database references 1 0 2001-03-21 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 1 4 2022-12-21 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details STRUCTURE OF BCL-XL/BAK PEPTIDE COMPLEX, NMR, MINIMIZED AVERAGE STRUCTURE Complex of Bcl-xL with peptide from Bad Human Bcl-2, isoform 2 RCSB Y RCSB 2000-11-01 REL 1 3D_15N-separated_NOESY 3D_13C-separated_NOESY 20 mM 7.8 ambient 298 K simulated annealing 15N-Bcl-2(1); 15N,13C-BCL-2(1) H2O 15N,13C-Bcl-2(1) D2O Brunger refinement CNX 2000 800 Bruker AVANCE 600 Bruker AVANCE 500 Bruker AVANCE n 1 1 A n 2 2 A HIS 3 n 3 HIS 3 A ALA 4 n 4 ALA 4 A GLY 5 n 5 GLY 5 A ARG 6 n 6 ARG 6 A THR 7 n 7 THR 7 A GLY 8 n 8 GLY 8 A TYR 9 n 9 TYR 9 A ASP 10 n 10 ASP 10 A ASN 11 n 11 ASN 11 A ARG 12 n 12 ARG 12 A GLU 13 n 13 GLU 13 A ILE 14 n 14 ILE 14 A VAL 15 n 15 VAL 15 A MET 16 n 16 MET 16 A LYS 17 n 17 LYS 17 A TYR 18 n 18 TYR 18 A ILE 19 n 19 ILE 19 A HIS 20 n 20 HIS 20 A TYR 21 n 21 TYR 21 A LYS 22 n 22 LYS 22 A LEU 23 n 23 LEU 23 A SER 24 n 24 SER 24 A GLN 25 n 25 GLN 25 A ARG 26 n 26 ARG 26 A GLY 27 n 27 GLY 27 A TYR 28 n 28 TYR 28 A GLU 29 n 29 GLU 29 A TRP 30 n 30 TRP 30 A ASP 31 n 31 ASP 31 A ALA 32 n 32 ALA 32 A GLY 33 n 33 GLY 33 A ASP 34 n 34 ASP 34 A ASP 35 n 35 ASP 35 A VAL 36 n 36 VAL 36 A GLU 37 n 37 GLU 37 A GLU 38 n 38 GLU 38 A ASN 39 n 39 ASN 39 A ARG 40 n 40 ARG 40 A THR 41 n 41 THR 41 A GLU 42 n 42 GLU 42 A ALA 43 n 43 ALA 43 A PRO 44 n 44 PRO 44 A GLU 45 n 45 GLU 45 A GLY 46 n 46 GLY 46 A THR 47 n 47 THR 47 A GLU 48 n 48 GLU 48 A SER 49 n 49 SER 49 A GLU 50 n 50 GLU 50 A VAL 92 n 51 VAL 92 A VAL 93 n 52 VAL 93 A HIS 94 n 53 HIS 94 A LEU 95 n 54 LEU 95 A ALA 96 n 55 ALA 96 A LEU 97 n 56 LEU 97 A ARG 98 n 57 ARG 98 A GLN 99 n 58 GLN 99 A ALA 100 n 59 ALA 100 A GLY 101 n 60 GLY 101 A ASP 102 n 61 ASP 102 A ASP 103 n 62 ASP 103 A PHE 104 n 63 PHE 104 A SER 105 n 64 SER 105 A ARG 106 n 65 ARG 106 A ARG 107 n 66 ARG 107 A TYR 108 n 67 TYR 108 A ARG 109 n 68 ARG 109 A GLY 110 n 69 GLY 110 A ASP 111 n 70 ASP 111 A PHE 112 n 71 PHE 112 A ALA 113 n 72 ALA 113 A GLU 114 n 73 GLU 114 A MET 115 n 74 MET 115 A SER 116 n 75 SER 116 A SER 117 n 76 SER 117 A GLN 118 n 77 GLN 118 A LEU 119 n 78 LEU 119 A HIS 120 n 79 HIS 120 A LEU 121 n 80 LEU 121 A THR 122 n 81 THR 122 A PRO 123 n 82 PRO 123 A PHE 124 n 83 PHE 124 A THR 125 n 84 THR 125 A ALA 126 n 85 ALA 126 A ARG 127 n 86 ARG 127 A GLY 128 n 87 GLY 128 A ARG 129 n 88 ARG 129 A PHE 130 n 89 PHE 130 A ALA 131 n 90 ALA 131 A THR 132 n 91 THR 132 A VAL 133 n 92 VAL 133 A VAL 134 n 93 VAL 134 A GLU 135 n 94 GLU 135 A GLU 136 n 95 GLU 136 A LEU 137 n 96 LEU 137 A PHE 138 n 97 PHE 138 A ARG 139 n 98 ARG 139 A ASP 140 n 99 ASP 140 A GLY 141 n 100 GLY 141 A VAL 142 n 101 VAL 142 A ASN 143 n 102 ASN 143 A TRP 144 n 103 TRP 144 A GLY 145 n 104 GLY 145 A ARG 146 n 105 ARG 146 A ILE 147 n 106 ILE 147 A VAL 148 n 107 VAL 148 A ALA 149 n 108 ALA 149 A PHE 150 n 109 PHE 150 A PHE 151 n 110 PHE 151 A GLU 152 n 111 GLU 152 A PHE 153 n 112 PHE 153 A GLY 154 n 113 GLY 154 A GLY 155 n 114 GLY 155 A VAL 156 n 115 VAL 156 A MET 157 n 116 MET 157 A CYS 158 n 117 CYS 158 A VAL 159 n 118 VAL 159 A GLU 160 n 119 GLU 160 A SER 161 n 120 SER 161 A VAL 162 n 121 VAL 162 A ASN 163 n 122 ASN 163 A ARG 164 n 123 ARG 164 A GLU 165 n 124 GLU 165 A MET 166 n 125 MET 166 A SER 167 n 126 SER 167 A PRO 168 n 127 PRO 168 A LEU 169 n 128 LEU 169 A VAL 170 n 129 VAL 170 A ASP 171 n 130 ASP 171 A ASN 172 n 131 ASN 172 A ILE 173 n 132 ILE 173 A ALA 174 n 133 ALA 174 A LEU 175 n 134 LEU 175 A TRP 176 n 135 TRP 176 A MET 177 n 136 MET 177 A THR 178 n 137 THR 178 A GLU 179 n 138 GLU 179 A TYR 180 n 139 TYR 180 A LEU 181 n 140 LEU 181 A ASN 182 n 141 ASN 182 A ARG 183 n 142 ARG 183 A HIS 184 n 143 HIS 184 A LEU 185 n 144 LEU 185 A HIS 186 n 145 HIS 186 A THR 187 n 146 THR 187 A TRP 188 n 147 TRP 188 A ILE 189 n 148 ILE 189 A GLN 190 n 149 GLN 190 A ASP 191 n 150 ASP 191 A ASN 192 n 151 ASN 192 A GLY 193 n 152 GLY 193 A GLY 194 n 153 GLY 194 A TRP 195 n 154 TRP 195 A ASP 196 n 155 ASP 196 A ALA 197 n 156 ALA 197 A PHE 198 n 157 PHE 198 A VAL 199 n 158 VAL 199 A GLU 200 n 159 GLU 200 A LEU 201 n 160 LEU 201 A TYR 202 n 161 TYR 202 A GLY 203 n 162 GLY 203 A PRO 204 n 163 PRO 204 A SER 205 n 164 SER 205 A MET 206 n 165 MET 206 A ARG 207 n 166 ARG 207 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A MET 1 A MET 1 1 Y 1 A ALA 2 A ALA 2 1 Y 1 A ALA 4 65.43 -78.91 1 A ARG 6 -179.88 126.26 1 A THR 7 -177.52 58.70 1 A ASP 10 63.13 62.91 1 A TYR 28 -47.21 106.11 1 A TRP 30 -96.38 -66.27 1 A ALA 32 75.77 -58.70 1 A VAL 36 178.95 107.83 1 A PRO 44 -59.75 82.04 1 A SER 49 -147.25 38.10 1 A TYR 108 -78.95 -70.05 1 A PHE 112 68.54 -84.95 1 A HIS 120 -67.38 -123.10 1 A LEU 121 179.06 98.07 1 A THR 122 167.37 164.50 1 A THR 125 -128.17 -56.22 1 A ASP 140 -106.95 76.38 1 A ARG 183 -65.89 -73.51 1 A PRO 204 -57.86 -158.80 1 A SER 205 -118.26 79.10 HUMAN BCL-2, ISOFORM 1 1 N N A ASP 10 A ASP 10 HELX_P A GLN 25 A GLN 25 1 1 16 A VAL 92 A VAL 51 HELX_P A ARG 109 A ARG 68 1 2 18 A ALA 113 A ALA 72 HELX_P A GLN 118 A GLN 77 5 3 6 A THR 122 A THR 81 HELX_P A PHE 138 A PHE 97 1 4 17 A ASN 143 A ASN 102 HELX_P A ARG 164 A ARG 123 1 5 22 A MET 166 A MET 125 HELX_P A HIS 184 A HIS 143 1 6 19 A HIS 184 A HIS 143 HELX_P A GLY 193 A GLY 152 1 7 10 A GLY 194 A GLY 153 HELX_P A GLY 203 A GLY 162 1 8 10 APOPTOSIS APOPTOSIS BCL2_HUMAN UNP 1 P10415 BCLX_HUMAN UNP 1 Q07817 1 34 1G5M 1 34 P10415 A 1 1 34 29 44 1G5M 35 50 Q07817 A 2 35 50 92 207 1G5M 92 207 P10415 A 1 51 166 1 THR variant ALA 96 1G5M A P10415 UNP 96 55 1 ARG variant GLY 110 1G5M A P10415 UNP 110 69 1 P 1